| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |